Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Prostatic Neoplasms 1 Nevus 1 Melanoma 1 Lung Neoplasms 1 Dysplastic Nevus Syndrome 1 Breast Neoplasms 1

Interventions

Nivolumab 13 Ipilimumab 10 pembrolizumab 8 cemiplimab 6 Surveys and Questionnaires 6 Biopsy 6 aldesleukin 5 Radiotherapy 5 Interleukin-2 5 Blood Specimen Collection 5 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Mohs Surgery 4 HhAntag691 4 Fluorouracil 4 Educational Status 4 Cyclophosphamide 4 sonidegib 3 fludarabine phosphate 3 fludarabine 3 avelumab 3 Vemurafenib 3 Surgical Procedures, Operative 3 Radiation 3 Petrolatum 3 Cetuximab 3 Aminolevulinic Acid 3 trametinib 2 dabrafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Neoplasms × Genome × Clear all

NCT05446155 2024-01-23

BioMEL

Region Skane

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡